Discover
CLOV
Clover Health Investments, Corp.
5.39
2 x 3.94
2 x 6.65
bid
ask
+
0.15
2.86%
2 @ 05:37 AM
5.40 +0.01 (0.19%)
| Ytd | 129.36% | |
| 1y | 96.00% |
5.12
day range
5.54
1.58
52 week range
5.59
| Open | 5.25 | Prev Close | 5.24 | Low | 5.12 | High | 5.54 | Mkt Cap | 2.84B |
| Vol | 7.85M | Avg Vol | 7.67M | EPS | -0.12 | P/E | N/A | Forward P/E | 52.40 |
| Beta | 2.48 | Short Ratio | 2.66 | Inst. Own | 30.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 3.80 | 200-d Avg | 2.80 | 1yr Est | 4.15 |
| Income Statement | |||
| Total Revenue | 749.19M | ||
| Revenues (USD) | 749.19M | ||
| Cost of Revenue | 589.65M | ||
| Gross Profit | 159.54M | ||
| Operating Expenses | 132.21M | ||
| Selling, General and Administrative Expense | 131.69M | ||
| Operating Income | 27.33M | ||
| Net Income | 27.33M | ||
| Net Income Common Stock | 27.33M | ||
| Net Income Common Stock (USD) | 27.33M | ||
| Consolidated Income | 27.33M | ||
| Earnings per Basic Share | 0.05 | ||
| Earnings per Basic Share (USD) | 0.05 | ||
| Earnings per Diluted Share | 0.05 | ||
| Earning Before Interest & Taxes (EBIT) | 27.33M | ||
| Earning Before Interest & Taxes (USD) | 27.33M | ||
| Weighted Average Shares | 522.18M | ||
| Weighted Average Shares Diluted | 532.50M | ||
| Balance Sheet | |||
| Cash and Equivalents | 173.27M | ||
| Cash and Equivalents (USD) | 173.27M | ||
| Investments | 244.96M | ||
| Investments Current | 30.28M | ||
| Investments Non-Current | 214.68M | ||
| Trade and Non-Trade Receivables | 73.47M | ||
| Current Assets | 448.02M | ||
| Property, Plant & Equipment Net | 6.90M | ||
| Total Assets | 697.73M | ||
| Current Liabilities | 336.58M | ||
| Total Liabilities | 358.30M | ||
| Accumulated Retained Earnings (Deficit) | -2.26B | ||
| Accumulated Other Comprehensive Income | -672.00K | ||
| Shareholders Equity | 339.43M | ||
| Shareholders Equity (USD) | 339.43M | ||
| Assets Non-Current | 249.71M | ||
| Goodwill and Intangible Assets | 2.99M | ||
| Liabilities Non-Current | 21.72M | ||
| Trade and Non-Trade Payables | 299.59M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 515.00K | ||
| Net Cash Flow from Financing | -7.86M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 94.96M | ||
| Capital Expenditure | -854.00K | ||
| Issuance (Purchase) of Equity Shares | -7.86M | ||
| Net Cash Flow from Investing | -5.07M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -4.21M | ||
| Net Cash Flow from Operations | 107.90M | ||
| Share Based Compensation | 12.27M | ||